About
Akira Matsuno is a biotech executive and company builder who serves as Co-Founder, President, CFO, and COO of Tune Therapeutics, an epigenetic-programming company developing gene, cell, and regenerative therapies. Before Tune, he was CFO and Head of Corporate Development at Lyell Immunopharma and previously held leadership roles at Juno Therapeutics. Tune and Ropes & Gray also note that he co-founded JW Therapeutics and has led major financing, partnership, and transaction work across cell and gene therapy.
Areas of interest
biotechcell therapygene therapyepigenetic programmingregenerative medicinecorporate developmentbiopharma financestrategic partnershipsgenome engineering